FDA Drug Recalls Explained
What recall classes mean, why drugs get recalled, and what to do if your medication is affected.
Most drug recalls are Class II (temporary or reversible health problems, or remote probability of serious harm). Do not stop taking a prescribed medication because of a recall without consulting your pharmacist or doctor — the risk of abruptly stopping may be greater than the recall risk. Your pharmacist can check your specific lot number and provide a replacement if needed.
Why Drug Recalls Happen
Drug recalls can be alarming, but they are a sign that the safety monitoring system is working. The FDA tracks drug quality through inspections, adverse event reports, and manufacturer self-reporting. When a problem is identified — contamination, incorrect dosage, mislabeling, manufacturing defects — the affected products are pulled from distribution.
The most common causes of recalls are manufacturing defects (contamination, incorrect potency, particulate matter), labeling errors (wrong dosage listed, missing warnings), and quality failures at manufacturing facilities. Less commonly, new safety information discovered after approval can trigger market withdrawals. PlainMeds tracks active recalls from FDA Enforcement Reports so you can check your medications.
Understanding Recall Classifications
The FDA classifies recalls into three levels based on potential health risk:
What it tells you: Class I recalls involve situations where the product could cause serious health consequences or death. These are rare and urgent — typically involving contamination with dangerous substances, severely incorrect dosage strengths, or mislabeled products that could lead to therapeutic failure in life-threatening conditions. Class II recalls are the most common, involving products that may cause temporary or medically reversible health problems. Class III recalls involve products unlikely to cause adverse health consequences — often labeling technicalities or minor regulatory violations.
What it doesn't tell you: The recall class indicates the FDA's assessment of potential risk, not the actual harm that has occurred. A Class I recall might be issued preventively before any adverse events are reported. Conversely, the absence of a recall does not guarantee a drug is free of quality issues — the FDA relies heavily on manufacturer self-reporting and cannot inspect every batch.
How to use it: When you see a recall on PlainMeds or the FDA website, check the class first. For Class III, the urgency is low. For Class II, contact your pharmacist at your next refill to verify your lot. For Class I, contact your pharmacist immediately. In all cases, do not stop a prescribed medication without professional guidance.
Checking Your Medications
Step 1 — Identify your lot number. Every prescription bottle has a lot number (also called batch number) printed on the label. This is the key piece of information that determines whether your specific bottle is affected by a recall.
Step 2 — Check the recall notice. FDA recall announcements list specific lot numbers. Search your medication on PlainMeds to see any active enforcement actions, or check the FDA recall database directly.
Step 3 — Contact your pharmacist. Your pharmacist can check whether your dispensed lot is affected and provide a replacement from a different manufacturer if needed. Most pharmacies track lot numbers in their dispensing records.
Step 4 — Report adverse events. If you experienced problems with a recalled medication, report it to the FDA MedWatch program. Post-marketing reports help the FDA identify safety signals and protect other patients.
Frequently Asked Questions
Recall Classification Comparison Table
| Classification | Health Risk Level | Example Trigger | Patient Action |
|---|---|---|---|
| Class I | Serious harm or death | NDMA contamination in ranitidine | Contact pharmacist immediately |
| Class II | Temporary or reversible harm | Dissolution test failure (wrong release rate) | Verify at next refill |
| Class III | Unlikely to cause harm | Label typo, packaging defect | No urgent action needed |
Worked Example: Responding to a Valsartan Recall
In 2018-2019, multiple manufacturers recalled valsartan (a blood pressure medication) due to NDMA contamination — a probable human carcinogen found in the active ingredient. Here is how the four-step process applies:
- Identify: Check your prescription bottle for the generic name (valsartan), manufacturer name, and lot number. Not all manufacturers were affected.
- Check: Look up valsartan on PlainMeds or the FDA recall database. Match your manufacturer and lot number against the affected list.
- Contact: If your lot is affected, contact your pharmacist immediately. They can provide valsartan from an unaffected manufacturer. Do not stop your blood pressure medication abruptly — uncontrolled hypertension is a more immediate risk than low-level NDMA exposure.
- Monitor: Report any adverse events to FDA MedWatch. The long-term cancer risk from months of low-level NDMA exposure is still being studied, but the immediate priority is maintaining blood pressure control with a clean product.
What are the three classes of FDA drug recalls?
Class I: serious health consequences or death possible. Class II: temporary or reversible problems, remote serious harm probability. Class III: unlikely to cause adverse consequences. Most recalls are Class II.
How do I check if my medication has been recalled?
Check PlainMeds drug profiles for active enforcement actions, the FDA recall database at fda.gov, or ask your pharmacist. Have your lot number from the prescription bottle ready.
What should I do if my medication is recalled?
Do not stop taking a prescribed medication without consulting your doctor or pharmacist. Contact your pharmacist first — they can check your lot number and provide a replacement. For Class I recalls, contact them immediately.
Why are so many generic drugs recalled?
Generics represent about 90% of prescriptions dispensed, so they naturally account for more recalls. Manufacturing is also concentrated — a few large manufacturers produce generics for hundreds of drugs, and facility problems can trigger recalls across many products.
Sources: U.S. Food and Drug Administration, FDA Recalls Database; FDA, openFDA Enforcement Reports.
Last updated: April 2026
Understanding the Data
The information presented throughout this guide is informed by publicly available public records published by federal and state government agencies. Our database aggregates and standardizes these records to make them more accessible and easier to interpret for general audiences. When we reference specific statistics or trends, they are drawn directly from these authoritative sources unless explicitly noted otherwise.
It is important to understand the limitations of any large-scale data dataset. Records may contain errors from the original data collection process, some fields may be incomplete for older entries, and classification systems may have changed over time. Our analysis accounts for these factors by clearly labeling data vintage, flagging records with missing critical fields, and noting when temporal comparisons span methodology changes in the source data.
For readers who want to conduct their own research, we recommend going directly to the source whenever possible. federal and state government agencies provides detailed documentation on collection methodology, sampling frames, and known data quality issues. Our goal is not to replace primary sources but to make them more approachable and to highlight patterns that may not be immediately obvious when browsing raw records.
How We Analyze Data Records
Our analytical approach involves several steps designed to surface meaningful insights from large datasets. First, we clean and standardize the raw data, handling variations in naming conventions, date formats, and categorical labels. Then we compute summary statistics, distributions, and comparative benchmarks across relevant dimensions such as geography, time period, and category type.
Key metrics we examine include statistical records, geographic distributions, temporal trends. These indicators provide a multi-dimensional view of each entity in our database, allowing users to understand not just individual records but how they compare to peers, regional averages, and national benchmarks. We believe this contextual approach is far more valuable than presenting raw numbers in isolation.